Search Results 91-100 of 8322 for imiquimod

  1. JSI-1187-01 Monotherapy And In Combination With Dabrafenib For Advanced Solid Tumors With MAPK Pathway Mutations - Mayo Clinic

    The purpose of this study is to evaluate JSI-1187 as monotherapy and in combination with dabrafenib for the treatment of advanced solid tumors with MAPK pathway ...

  2. MC250710 A Study Of Oral IRAK-4 Inhibitor CA-4948 In Combination With Pembrolizumab And Stereotactic Radiosurgery In Patients With Melanoma Brain Metastases - Mayo Clinic

    The purpose of this study is to investigate the use of the novel oral IRAK-4 inhibitor CA-4948 in combination with pembrolizumab therapy following stereotactic ...

  3. CODY: A Study Evaluating The Safety And Efficacy Of QTORIN 3.9% Sirolimus Topical Gel For The Prevention Of Basal Cell Carcinomas (BCCs) In Patients With Gorlin Syndrome - Mayo Clinic

    5-fluorouracil, imiquimod, diclofenac, ingenol mebutate (topical); itraconazole, SUBA-itraconazole (systemic) within the 3 months prior to Day 0;; Hedgehog ...

  4. Axatilimab Plus Standard Of Care Therapy For The Prevention Of Graft Versus Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation In Patients With Hematologic Cancer, ABRAXAS Trial - Mayo Clinic

    This phase II trial studies how well adding axatilimab to standard of care (SOC) therapy works in preventing graft versus host disease (GVHD) following ...

  5. Sitagliptin and metformin (oral route) - Side effects & dosage - Mayo Clinic

    Sitagliptin and metformin combination is used together with proper diet and exercise to treat high blood sugar levels caused by type 2 diabetes. Sitagliptin ...

  6. Inotuzumab Ozogamicin In Treating Younger Patients With Relapsed Or Refractory CD22 Positive B Acute Lymphoblastic Leukemia - Mayo Clinic

    Immunotoxins, such as inotuzumab ozogamicin, are antibodies linked to a toxic substance and may help find cancer cells that express CD22 and kill them without ...

  7. Filgotinib In Long-Term Extension Study Of Adults With Ulcerative Colitis - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  8. Phase 2 Study To Evaluate The Oral Combination Of Ixazomib (MLN9708) With Cyclophosphamide And Dexamethasone In Patients With Newly Diagnosed Or Relapsed And/or Refractory Multiple Myeloma - Mayo Clinic

    About this study. This is a phase 2, multicenter, open-label study in patients with Newly Diagnosed Multiple Myeloma (NDMM) who have not received prior ...

  9. A Study Of Emiltatug Ledadotin (Emi-Le) In Participants With Solid Tumors - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  10. Glioma Clinical Trials - Mayo Clinic Research

    RATIONALE: Radiation therapy uses high-energy x-rays to kill tumor cells. Specialized radiation therapy that delivers a high dose of radiation directly to the ...